AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
TuHURA Biosciences, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001V0HK36
2.18▲ 0.17 (8.46%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
2.01
Day's Range
2.05 – 2.19
52-Week Range
0.41 – 3.43
Volume
987.0K
Avg Volume
263.8K
Share Statistics
Shares Outstanding
Employees
22
Exchange
XNAS
Listed
2024-10-18
Share count as of August 11, 2026

TuHURA Biosciences, Inc. Common Stock (HURA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about TuHURA Biosciences, Inc. Common Stock (HURA)
What is TuHURA Biosciences, Inc. Common Stock's Market Cap?
TuHURA Biosciences, Inc. Common Stock's Market Cap is $138.9M, based on as-reported figures from SEC (XBRL) filings.
What is TuHURA Biosciences, Inc. Common Stock's Enterprise Value?
TuHURA Biosciences, Inc. Common Stock's Enterprise Value is $141.5M, based on as-reported figures from SEC (XBRL) filings.
What is TuHURA Biosciences, Inc. Common Stock's EV / EBITDA?
TuHURA Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is TuHURA Biosciences, Inc. Common Stock's Revenue (TTM)?
TuHURA Biosciences, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is TuHURA Biosciences, Inc. Common Stock's Net Income (TTM)?
TuHURA Biosciences, Inc. Common Stock's Net Income (TTM) is -$30.6M, based on as-reported figures from SEC (XBRL) filings.
What is TuHURA Biosciences, Inc. Common Stock's EBITDA?
TuHURA Biosciences, Inc. Common Stock's EBITDA is -$29.9M, based on as-reported figures from SEC (XBRL) filings.
What is TuHURA Biosciences, Inc. Common Stock's Diluted EPS (TTM)?
TuHURA Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -0.48, based on as-reported figures from SEC (XBRL) filings.
What is TuHURA Biosciences, Inc. Common Stock's Net Debt?
TuHURA Biosciences, Inc. Common Stock's Net Debt is $2.6M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · HURAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Research and development expenses
Acquisition-related costs————
General and administrative expenses
Operating Loss
Other (Expense) Income:
Grant income——
Interest expense
Interest income
Change in fair value of derivative liability————
Total Other (Expense) Income
Net Loss
Series A Preferred cash dividend
Net Loss attributable to common stockholders
Net Loss per share, basic
Net Loss per share, diluted